RPRX

Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference: Pivot to Growth Strategy Delivering Growth and Transforming through Innovation

01/11 07:00 pm

Royalty Pharma and Teva Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo

01/11 06:15 pm

Teva and Royalty Pharma Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo

01/11 06:00 pm

Royalty Pharma Announces Dividend Increase

01/09 09:30 am

Merck In Talks To Buy Cancer Drug-Maker Revolution Medicines In A $28 To $32 Billion Deal — Stock Soars Overnight

01/09 02:52 am

What's Going On With Royalty Pharma Stock Wednesday?

12/31 11:47 am

Royalty Pharma Acquires Remaining Royalty Interest in Roche's Evrysdi for $240 Million and Potential Milestones

12/29 05:40 pm

Cytokinetics Reports Third Quarter 2025 Financial Results and Provides Business Update

11/05 05:00 pm

Royalty Pharma Announces Pricing of $2.0 Billion of Senior Unsecured Notes

09/02 08:30 pm

Royalty Pharma to Acquire Royalty Interest in Amgen's Imdelltra for up to $950 Million

08/25 06:10 am

Royalty Pharma Declares Third Quarter 2025 Dividend

07/18 08:15 am

Royalty Pharma Completes the Acquisition of Its External Manager

05/16 04:30 pm

Royalty Pharma Announces Shareholder Approval of its External Manager Acquisition

05/12 04:15 pm

Royalty Pharma Declares Second Quarter 2025 Dividend

04/21 04:15 pm

Biogen Q4 Earnings: Revenue And EPS Beat, Warns Lower 2025 Revenue, Inks R&D Funding Pact With Royalty Pharma

02/12 10:39 am

Royalty Pharma Announces Transformative Step in Company's Evolution With Acquisition of its External Manager and $3 Billion Share Repurchase Program

01/10 08:15 am

3 High-Yield Dividend Stocks to Buy in 2025 and Hold for a Decade or Longer

12/13 05:30 am

2 Exceptional Dividend Stocks Near 52-Week Lows You Could Regret Not Buying on the Dips

12/04 06:37 am

3 High-Yield Dividend Stocks You Can Buy With $130 Now and Hold at Least a Decade

11/14 06:20 am

3 Dividend Growth Stocks to Buy Now for a Lifetime of Passive Income

10/20 06:24 am

Royalty Pharma Declares Fourth Quarter 2024 Dividend

10/11 08:15 am

2 No-Brainer Dividend Stocks to Buy With $100 in October

10/01 04:43 am

3 High-Yield Dividend Stocks Down by More Than 39% to Buy Now and Hold at Least a Decade

09/16 05:23 am

Agios to Receive $1.1 Billion in Milestone Payments Following FDA Approval of Vorasidenib

08/06 05:50 pm

Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?

06/18 06:20 am

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields

06/12 09:15 am

Royalty Pharma to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

06/04 04:15 pm

Agios (AGIO) Up 21% on Upbeat Data From 2nd Thalassemia Study

06/04 12:44 pm

Royalty Pharma Announces Pricing of $1.5 Billion of Senior Unsecured Notes

06/03 05:15 pm

Agios (AGIO) Up 23% on Selling Brain Cancer Drug Royalty

05/29 12:35 pm

Royalty Pharma and Agios Pharmaceuticals Enter Into Vorasidenib Royalty Agreement for $905 Million

05/28 07:10 am

Why Cytokinetics (CYTK) Stock Price Was Down 17% on Thursday

05/24 11:12 am

Heart Disease-Focused Cytokinetics Operations Are On Track Despite Acquisition Uncertainty, Analysts Observe

05/23 02:30 pm

Royalty Pharma and Cytokinetics Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline

05/22 04:10 pm

Royalty Pharma to Present at Upcoming Investor Conferences

05/13 08:15 am

Royalty Pharma (RPRX) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

05/09 12:00 pm

Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab

05/09 06:45 am

Crescent Capital BDC (CCAP) Q1 Earnings and Revenues Surpass Estimates

05/08 06:50 pm

Why Earnings Season Could Be Great for Royalty Pharma (RPRX)

05/08 08:51 am

Insights Into Royalty Pharma (RPRX) Q1: Wall Street Projections for Key Metrics

05/06 09:16 am

Here's What to Expect From Assurant's (AIZ) Q1 Earnings

05/03 09:28 am

Royalty Pharma (RPRX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

05/02 10:01 am

Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024

04/19 08:15 am

Royalty Pharma Declares Second Quarter 2024 Dividend

04/17 08:15 am

Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?

04/15 06:20 am

Royalty Pharma to Present at TD Cowen’s 44th Annual Health Care Conference

02/28 05:15 pm

Royalty Pharma (RPRX) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

02/16 04:30 pm

Wall Street Thinks These 3 Stocks Are Hidden Gems That Could Soar 43% to 59% Over the Next 12 Months

02/16 06:50 am

Royalty Pharma To Announce Fourth Quarter And Full Year 2023 Financial Results On February 15, 2024

01/30 05:15 pm

Royalty Pharma Announces Dividend Increase

01/19 09:15 am